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Protease-activated receptor 1 (PAR1) is a member of the G-protein coupled receptors 
that are proteolytically activated by serine proteases. Recent studies suggest a definite 
contribution of PAR1 to brain functions including learning and memory. However, 
cellular mechanisms by which PAR1 activation influences neuronal activity are not well 
understood. Here we show that PAR1 activation drives retrograde endocannabinoid 
signaling and thereby regulates synaptic transmission. In cultured hippocampal neurons 
from rat, PAR1 activation by thrombin or PAR1-specific peptide agonists transiently 
suppressed inhibitory transmission at cannabinoid-sensitive, but not 
cannabinoid-insensitive, synapses. The PAR1-induced suppression of synaptic 
transmission was accompanied by an increase in paired-pulse ratio, and was blocked by 
a cannabinoid CB1 receptor antagonist. The PAR1-induced suppression was blocked by 
pharmacological inhibition of postsynaptic diacylglycerol lipase (DGL), a key enzyme 
for biosynthesis of the major endocannabinoid 2-arachidonoylglycerol (2-AG), and was 
absent in knockout mice lacking the  isoform of DGL (DGL). The PAR1-induced 
IPSC suppression remained intact under the blockade of metabotropic glutamate 
receptors, and was largely resistant to the treatment that blocked Ca2+ elevation in glial 
cells following PAR1 activation, which exclude the major contribution of glial PAR1 in 
IPSC suppression. We conclude that activation of neuronal PAR1 triggers retrograde 
signaling mediated by 2-AG, which activates presynaptic CB1 receptors and suppresses 




Protease-activated receptors (PARs) are members of seven-transmembrane domain 
G-protein coupled receptors and consists of four subtypes (PAR1-PAR4) (Ossovskaya 
and Bunnett, 2004). Activation of PARs is initiated by a unique mechanism that 
protease cleaves a specific site within extracellular N terminus region of the receptor. 
This cleavage reveals a new N terminus, which acts as a tethered ligand and then binds 
and activates the receptor. PARs are abundantly expressed in the brain, and have been 
shown to play various roles in pathophysiological conditions such as neurogenic 
inflammation, neurodegeneration and neuroprotection (Ossovskaya and Bunnett, 2004; 
Luo et al., 2007).  
 PARs may also contribute to neural functions under physiological conditions. 
PAR1-deficient mice show defects in passive avoidance task, cued fear conditioning 
(Almonte et al., 2007) and nicotine-induced place preference (Nagai et al., 2006). At 
cellular levels, PAR1 activation influences synaptic transmission. PAR1 activation 
potentiated NMDA receptor currents (Gingrich et al., 2000; Mannaioni et al., 2008) and 
induced long-term potentiation (LTP) of excitatory transmission (Maggio et al., 2008) in 
CA1 pyramidal neurons of hippocampal slices, and enhanced spontaneous release of 
glutamate onto substantia gelatinosa neurons in spinal cord slices (Fujita et al., 2009). 
As to the mechanisms, several studies have demonstrated that PAR agonists activate 
astrocytic PAR1, rather than neuronal PAR1, induce glutamate release from astrocytes, 
and thereby activate neuronal NMDA receptors in hippocampal acute slices (Lee et al., 
2007; Mannaioni et al., 2008; Shigetomi et al., 2008) and hippocampal coculture 
preparations (Lee et al., 2007). In situ hybridization studies suggest that PAR1 is 
expressed in both astrocytes and neurons including hippocampal pyramidal and granule 
cells (Weinstein et al., 1995; Niclou et al., 1998). Our knowledge about roles of 
neuronal PAR1 in the regulation of synapic transmission is, however, rather limited, 
especially at inhibitory synapses. 
 5
 Endocannabinoid-mediated retrograde modulation of synaptic transmission 
plays important roles in various brain functions (Heifets and Castillo, 2009; Kano et al., 
2009). Endocannabinoids are released from postsynaptic neurons and retrogradely 
activate presynaptic CB1 receptors, which lead to suppression of transmitter release. 
Endocannabinoid release is induced by postsynaptic depolarization (Kreitzer and 
Regehr, 2001; Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001) and/or activation of 
several types of Gq/11-coupled receptors including group I metabotropic glutamate 
receptors (I-mGluRs) (Maejima et al., 2001). Activation of phospholipase C (PLC) 
through these receptors produces diacylglycerol (DG), which is then hydrolyzed by DG 
lipase  (DGL) and yields the endocannabinoid 2-arachidonoylglycerol (2-AG) 
(Hashimotodani et al., 2005; Maejima et al., 2005; Gao et al., 2010; Tanimura et al., 
2010). Importantly, PAR1 activates Gq/11 protein and stimulates phosphoinositide 
hydrolysis via PLC (Ossovskaya and Bunnett, 2004; McLaughlin et al., 2005). 
Therefore, it is likely that PAR1 activation can drive endocannabinoid signaling. This 
possibility, however, has never been tested electrophysiologically. In the present study, 
we used cannabinoid-sensitive inhibitory synapses of cultured hippocampal neurons, 
and demonstrated for the first time that neuronal PAR1 activation can modulate the 
synaptic transmission through the endocannabinoid 2-AG signaling. 
 
Materials and Methods  
Cell culture 
All experiments were performed according to the guidelines laid down by the animal 
welfare committees of the University of Tokyo, Kanazawa and Niigata Universities. 
Cultured hippocampal neurons were prepared from newborn Sprague-Dawley rats, 
PAR1 knockout mice (The Jackson Laboratory, Bar Harbor, ME) (Connolly et al., 1996), 
DGL knockout mice (Tanimura et al., 2010) and their wild-type littermates as 
described previously (Ohno-Shosaku et al., 2001). Animals with both sexes were used. 
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Briefly, cells were mechanically dissociated from the hippocampi and plated onto 
poly-L-ornithine-coated plastic dishes for electrophysiological experiments or 
low-fluorescence plastic films (Sumilon MS-92132, Sumitomo, Tokyo, Japan) for Ca2+ 
imaging. The cultures were kept at 36 °C in 5 % CO2 for 12-15 days before use. 
 
Electrophysiology 
Double whole-cell recordings were performed from cultured hippocampal neurons 
using a patch-clamp amplifier (EPC10/2; HEKA Electronik, Lambrecht/Pfalz, 
Germany). Each neuron of a pair was voltage clamped at -80 mV using a patch pipette 
(3-5 M) filled with the internal solution with the following compositions (in mM): 130 
K-gluconate, 15 KCl, 10 HEPES, 0.2 EGTA, 6 MgCl2, 5 Na2ATP and 0.2 Na2GTP (pH 
7.3, adjusted with KOH).  For the experiments shown in Figure 3E, we used the 
internal solution with the following compositions for postsynaptic neurons (in mM): 
109.6 (for pCa 6) or 121.8 (for pCa 9) K-gluconate, 15 KCl, 10 HEPES, 10 BAPTA, 
8.47 (for pCa 6) or 0.0549 (for pCa 9) CaCl2, 5 MgCl2, 5 Na2ATP and 0.2 Na2GTP (pH 
7.3, adjusted with KOH) (Hashimotodani et al., 2005). One neuron was stimulated by 
applying positive voltage pulses (to 0 mV, 2 ms) at 0.5 Hz or 0.25 Hz, and IPSCs were 
measured from the other neuron. The external solution contained (in mM): 140 NaCl, 
2.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose and 1 kynurenic acid (pH 7.3, 
adjusted with NaOH). The recording chamber was perfused with the external solution at 
a flow rate of 1-3 ml/min. Our culture preparations contain cannabinoid-sensitive and 
-insensitive inhibitory neurons (Ohno-Shosaku et al., 2001). The cannabinoid sensitivity 
of IPSCs was determined by triggering depolarization-induced suppression of inhibition 
(DSI), a form of endocannabinoid-mediated short-term depression (Alger, 2002). We 
defined cannabinoid-sensitive and -insensitive IPSCs by DSI-positive (> 30% of 
suppression) and DSI-negative (< 10% of suppression) IPSCs, respectively. PAR1 
activators (thrombin, TFLLR, SFLLRN) were locally applied for 1 min through a 
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capillary tube (250 m inner diameter) located near the recorded neurons using a 
perfusion valve controller (VC-6M; Warner Instruments, Hamden, CT). All experiments 
were performed at room temperature. 
 
Ca2+ imaging 
Hippocampal cultures on the films were incubated with 5 M fura-2 AM (Dojindo, 
Kumamoto, Japan) at 36 °C for 15 min and then transferred to a glass-based dish 
mounted with recording chamber and perfused with the external solution (see above); 1 
mM kynurenic acid was replaced with 0.1 M tetrodotoxin. Fluorescence signals for 
excitation of 340 nm and 380 nm were measured at 0.2 Hz by using an imaging system 
(Acquacosmos, Hamamatsu Photonics, Hamamatsu, Japan) mounted on an inverted 
microscope (IX70, Olympus, Tokyo, Japan). 
 
Drugs 
TFLLR-NH2, AM251, DHPG, MPEP, LY367385 and thapsigargin were purchased from 
Tocris Cookson (Bristol, UK). Thrombin, SFLLRN and tetrahydrolipstatin (THL) were 
purchased from Sigma-Aldrich (St. Louis, MO). LY367385 was dissolved in 
NaOH-containing water as a stock solution. TFLLR, SFLLRN, thrombin and DHPG 
were dissolved in water. Other drugs were dissolved in DMSO.  
 
Data analysis 
In each experiment, amplitudes of 10 consecutive IPSCs during application of receptor 
activators were averaged and normalized to the control values before application. 
Statistical significance was assessed by Student's t-test (Figs. 1, 2) or Mann-Whitney 
U-test (Fig. 3). One, two, and three asterisks indicate p < 0.05, p < 0.01, and p < 0.001, 




Activation of PAR1 induces IPSC suppression 
We first examined effects of PAR1 activation on hippocampal IPSCs, using an 
endogenous PAR activator, thrombin, and two PAR1-selective peptide agonists, TFLLR 
and SFLLRN. If PAR1 triggers endocannabinoid release, cannabinoid-sensitive IPSCs 
(see Materials and Methods) would be influenced selectively. As expected, local 
application of thrombin transiently suppressed cannabinoid-sensitive IPSCs 
(DSI-positive) (Fig. 1A), but not cannabinoid-insensitive IPSCs (DSI-negative) (Fig. 
1B). In the following experiments, we used only the cannabinoid-sensitive IPSCs. In 
most cases, suppression was recovered gradually from its peak even in the presence of 
thrombin. When thrombin application was repeated, the second application failed to 
suppress IPSCs (Fig. 1D, F), which can be explained by receptor desensitization 
(Kawabata et al., 1999). Similar suppressing effects on cannabinoid-sensitive IPSCs 
were observed with TFLLR (Fig. 1C) and SFLLRN (29.0  6.0 % of control). When 
TFLLR was applied repeatedly, the second application failed to suppress IPSCs (Fig. 1E, 
F). When TFLLR and thrombin were applied sequentially, IPSCs were suppressed only 
at the first application irrespective of the order (Fig. 1G-I), indicating the involvement 
of the same receptor. The involvement of PAR1 was further confirmed by the results 
showing that TFLLR-induced IPSC suppression was absent in PAR1 knockout mice 
(Fig. 1J-L). The IPSC suppression induced by thrombin or TFLLR was accompanied by 
an increase in paired-pulse ratio (Fig. 1M), which is generally used as a marker of 
presynaptic change. These results indicate that PAR1 activation induces presynaptic 
suppression of inhibitory transmission at cannabinoid-sensitive synapses. 
 
Endocannabinoid signaling is involved in PAR1-mediated IPSC suppression 
We next examined whether the PAR1-driven suppression of IPSCs is mediated by 
endocannabinoids. The IPSC suppressions induced by thrombin and TFLLR were both 
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abolished by the treatment with AM251 (Fig. 2A, B, E, F). Recent studies have revealed 
that 2-AG produced by DGL mediates retrograde synaptic suppression (Gao et al., 
2010; Tanimura et al., 2010). Therefore, we tested whether the PAR1-driven 
suppression of IPSCs is dependent on DGL, by using pharmacological and genetic 
tools. Treatment with a DGL inhibitor, THL, completely blocked both thrombin and 
TFLLR-induced IPSC suppression (Fig. 2C-F). In hippocampal neurons prepared from 
DGL knockout mice, TFLLR failed to suppress IPSCs (Fig. 2G-I). From these results, 
we conclude that PAR1 activation leads to production and release of 2-AG in a 
DGL-dependent manner and induces suppression of GABA release through activation 
of presynaptic CB1 receptors. 
 
2-AG is produced and released from postsynaptic neurons upon PAR1 activation 
We then examined whether 2-AG was produced within postsynaptic neurons upon 
PAR1 activation, by applying the DGL inhibitor THL to the postsynaptic neurons 
through patch pipettes. Effectiveness of postsynaptically-applied THL was estimated by 
monitoring DHPG (I-mGluR agonist)-induced and depolarization-induced IPSC 
suppressions (Fig. 2J), both of which were previously demonstrated to be blocked by 
bath applied THL in our preparations (Hashimotodani et al., 2007b; Hashimotodani et 
al., 2008). When THL was applied postsynaptically, thrombin and TFLLR-induced 
IPSC suppressions were reduced by similar degrees to DHPG- and 
depolarization-induced suppressions (Fig. 2J). These results clearly indicate that the 
IPSC suppression is mediated by 2AG that is produced and released from postsynaptic 
neurons upon PAR1 activation. 
 
Neuronal PAR1 is responsible for generation of endocannabinoid signaling 
A simple model for PAR1-driven 2-AG release is that PAR1 activation and 2-AG 
production occur in the same postsynaptic neuron. However, it is also possible that 
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PAR1 activation and 2-AG production occur in separate cells. Recent studies have 
demonstrated that astrocytes are able to release several gliotransmitters including 
glutamate, when cytosolic Ca2+ concentration is elevated (Perea et al., 2009). Therefore, 
it is possible that activation of astrocytic PAR1 causes Ca2+ elevation and thereby 
induces glutamate release, which then activates neuronal I-mGluRs (mGluR1 and /or 
mGluR5) and initiates 2AG production through I-mGluR-PLC-DGL pathway within 
the postsynaptic neuron. To test this possibility, effects of combined treatment with the 
mGluR1 antagonist LY367385 and the mGluR5 antagonist MPEP on PAR1-driven 
IPSC suppression were examined. This treatment blocked the IPSC suppression induced 
by the I-mGluR agonist DHPG, but failed to block thrombin- and TFLLR-induced 
suppressions of IPSCs (Fig. 3A).  
 To test whether gliotransmitters other than glutamate are involved, we treated 
culture preparations with thapsigargin to deplete Ca2+ stores, which is expected to block 
Ca2+ elevation and gliotransmitter release (Mothet et al., 2005). We confirmed that Ca2+ 
transients triggered by TFLLR application were completely blocked in 
thapsigargin-treated astrocytes (Fig. 3B, C). This treatment attenuated the 
TFLLR-induced suppression of IPSCs, but left a large part of suppression intact (Fig. 
3D). This thapsigargin-resistant component of IPSC suppression should be independent 
of gliotransmitters, and thus dependent on neuronal PAR1 rather than astrocytic PAR1. 
As to the thapsigargin-sensitive component, there are two possibilities. This component 
may be dependent on astrocytic PAR1 and mediated by gliotransmitters. Alternatively, 
this component may also be dependent on neuronal PAR1, but sensitive to thapsigargin, 
because neuronal PAR1 activation induces local Ca2+ elevation, which can enhance 
2-AG production. The endocannabinoid release driven by Gq/11-coupled receptors such 
as I-mGluR and M1/M3 receptors has been demonstrated to be dependent on basal Ca2+ 
concentration and enhanced by postsynaptic Ca2+ elevation (Hashimotodani et al., 
2007a). To examine the Ca2+ dependence of PAR1-driven 2-AG release, we dialyzed 
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thapsigargin-treated postsynaptic neurons with either pCa 6 or pCa 9 pipette solution 
(Hashimotodani et al., 2005). The TFLLR-induced IPSC suppression was more 
prominent in the neurons filled with the pCa 6 solution (Fig. 3E). Thus, the 
thapsigargin-sensitive component of IPSC suppression is likely to include a neuronal 
PAR1-dependent component. Taken together, we concluded that a large component of 
2-AG release, if not all, was gliotransmitter-independent and neuronal PAR1-dependent.  
 
Discussion 
In this study, we have shown for the first time that activation of neuronal PAR1 triggers 
retrograde 2-AG signaling. This PAR1-driven 2-AG signaling leads to suppression of 
inhibitory synaptic transmission through presynaptic CB1 receptors in hippocampal 
neurons. Because PAR1 and CB1 are distributed widely in the brain, this PAR1-CB1 
coupling is likely to be functional, and contribute to synaptic modulation throughout the 
brain, similarly to other endocannabinoid-producing receptors including glutamate 
(I-mGluR), acetylcholine (M1/M3), serotonin (5-HT2), oxytocin, orexin, and 
glucocorticoid receptors (Maejima et al., 2001; Kim et al., 2002; Haj-Dahmane and 
Shen, 2005; Best and Regehr, 2008; Kano et al., 2009).  
 Our results are supported by previous biochemical, anatomical and 
Ca2+-imaging studies. A biochemical study showed effects of thrombin on 
endocannabinoid levels in dorsal root ganglia (DRG) neurons (Vellani et al., 2008). The 
treatment of rat cultured DRG neurons with 100 nM thrombin elevated the levels of two 
major endocannabinoids, anandamide and 2-AG. The authors proposed a model in 
which PAR-PLCβ-DGL pathways mediate thrombin-induced 2-AG production. It has 
been reported that rat cultured hippocampal neurons exhibit PAR1-immnoreactivtiy and 
expression of mRNA (Gorbacheva et al., 2009). Furthermore, the study using 
Ca2+-imaging has demonstrated the presence of functional PAR1 in cultured 
hippocampal neurons (Bushell et al., 2006). Because neuronal PAR1 expression has 
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been also reported in brain slices (Weinstein et al., 1995; Niclou et al., 1998), we expect 
that neuronal PAR1-driven 2-AG signaling is functional also in vivo. However, cultured 
neurons could be different from the neurons in vivo in some aspects and we cannot 
exclude the possibility that PAR1 is up-regulated under culture conditions. Further 
studies with slice preparations are necessary to understand the physiological 
significance of the PAR1-driven 2-AG signaling. 
 Previous studies with hippocampal slices demonstrate that PAR1 activation 
positively regulates neuronal excitatory synaptic activity (Gingrich et al., 2000; Lee et 
al., 2007; Maggio et al., 2008; Mannaioni et al., 2008). To our best knowledge, there are 
no studies reporting PAR1-induced suppression of excitatory transmission. Considering 
that hippocampal excitatory transmission is much less sensitive to cannabinoids 
(Ohno-Shosaku et al., 2002), it is possible that 2-AG signaling triggered by PAR1 
activation is too weak to cause a detectable change in the excitatory transmission. We 
showed that PAR1-driven 2-AG signaling was shown to be independent of I-mGluR, 
indicating that PAR1-induced glutamate release from astrocytes (Lee et al., 2007) 
contributes little to 2-AG generation. The amount of glutamate released from astrocytes 
might be too small to trigger 2-AG synthesis in neurons. It is also possible that 
glia-neuron crosstalk was disconnected in our culture preparations, although a previous 
study clearly demonstrated that the crosstalk was intact even in culture (Lee et al., 
2007). 
       In the hippocampus, PAR1 activators could exert opposite actions on excitatory 
and inhibitory synaptic transmissions. The potentiation of excitation is mediated by 
astrocytic PAR1 and gliotransmitters (Lee et al., 2007; Mannaioni et al., 2008), and the 
suppression of inhibition is mediated by neuronal PAR1 and endocannabinoids. If these 
two pathways are driven simultaneously, the excitatory signal is synergistically 
potentiated and LTP induction may be facilitated. The finding that PAR1 triggers 2-AG 
signaling provides a new insight into the roles of PAR1 under not only physiological but 
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also pathological conditions. The endocannabinoid system has also been reported to be 
associated with neurodegeneration and neuroprotection (Fowler et al., 2010). It will be 
of great interest to investigate whether PAR1-driven 2-AG signaling contributes to the 
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Thrombin and PAR1 agonists induce transient suppression of IPSCs. 
A-C, (top) Representative IPSC traces before (left) and during (right) application of 
thrombin (1 U/ml, red) or TFLLR (10 M, blue). Each trace is the average of five 
IPSCs. (bottom) Normalized IPSC time course during application of PAR1 activators. 
Data were obtained from cannabinoid-sensitive (A, C) and cannabinoid-insensitive (B) 
IPSCs. (Insets) Representative data showing positive (A) and negative (B) DSI 
responses. A depolarizing pulse (5 s, 0 mV) was applied to the postsynaptic neuron at 
time zero. D-F, Representative experiments (D, E) and summary bar graph (F) for the 
effects of repeated application of thrombin or TFLLR. Two IPSC traces acquired before 
(black) and during application of thrombin (red) or TFLLR (blue) are superimposed in 
each sample record in insets. G-I, Effects of sequential application of thrombin (Thr) 
and TFLLR (TF), illustrated similarly to D-F.  J-L, Effects of TFLLR (10 M) on 
IPSCs in WT and PAR1-KO mice. Two IPSC traces acquired before (black) and during 
(pink) application of thrombin or TFLLR are superimposed in each sample record in 
insets. M, (left) Examples of IPSC traces in response to paired stimuli (60 ms interval) 
before (black) and during application of thrombin (red) or TFLLR (blue). (right) 
Averaged data for the increase in paired-pulse ratio by thrombin and TFLLR. Numbers 




Involvement of endocannabinoid signaling in PAR1-induced IPSC suppression. 
A-D, Representative data showing effects of AM251 (0.3 M, A, B) and THL (5 M, C, 
D) on IPSC suppression induced by thrombin (1U/ml) or TFLLR (10 M). 
Representative IPSC traces acquired before (left) and during application of thrombin or 
TFLLR (right) are shown in insets of each panel. E, F, Summary graph showing 
normalized IPSC amplitudes during application of thrombin (E) or TFLLR (F) in the 
presence of AM251 and THL. G-I, TFLLR-induced IPSC suppression is absent in 
DGL-KO mice. Data are illustrated similarly to Figure 1J-L. J, Intracellular 
application of THL (10 M) to a postsynaptic neuron greatly reduced IPSC 
suppressions by thrombin (1U/ml), TFLLR (10 M), DHPG (20 M), and postsynaptic 
depolarization (5 s) to the similar extents. Filled and open columns represent normalized 
IPSC amplitudes for control and THL injected neurons. 
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Figure 3 
Neuronal PAR1, rather than glial PAR1, is responsible for generation of 2-AG signaling. 
A, Normalized IPSC amplitudes during application of thrombin (1U/ml), TFLLR (10 
M) and DHPG (20 M) in the presence (open columns) or absence (filled columns) of 
a mixture of MPEP (5 M) and LY367385 (100 M). B, C, Representative data (B) and 
summary graph (C) showing complete suppression of TFLLR-induced Ca2+ elevation in 
glial cells by thapsigargin (1 M). D, Normalized IPSC amplitudes during application 
of TFLLR (10 M) after treatment with thapsigargin (1 M) for 1 h (open column). The 
control data without thapsigargin-treatment (filled column, presented in Fig. 2F) are 
shown for comparison. E, TFLLR-induced IPSC suppression was dependent on 
postsynaptic Ca2+ concentration. After treatment with thapsigargin (1 M, 1 h), TFLLR 
(10 M) was applied to the postsynaptic neurons dialyzed with two different pipette 
solutions, pCa 6 (n = 7) and pCa 9 (n = 8). Results from non-treated neurons (Fig. 1C) 
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